Ligand Pharmaceuticals | Betriebsaufwand



Operating Expenses Veränderung Datum
Amgen USD 6.78B 401M 2024-12
Arrowhead Research USD 163.91M 1.71M 2024-12
Baxter International USD 3.19B 644M 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Glaxosmithkline GBP 7.42B 408M 2024-12
Insmed USD 334.86M 28M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
Ligand Pharmaceuticals USD 52.45M 3.78M 2024-12
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 11.33B 1.4B 2024-12
Pacira USD 162.55M 145.55M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Veracyte USD 114.46M 10.61M 2024-12



Ligand Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.